Patients Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment

Transcription

1 World J Surg (2015) 39: DOI /s ORIGINAL SCIENTIFIC REPORT Patients Preferences for Surgical Management of Esophageal Cancer: A Discrete Choice Experiment Esther W. de Bekker-Grob 1 Eva J. Niers 2 J. Jan B. van Lanschot 2 Ewout W. Steyerberg 1 Bas P. L. Wijnhoven 2 Published online: 14 July 2015 The Author(s) This article is published with open access at Springerlink.com Abstract Background Obtaining insight into patients preferences is important to optimize cancer care. We investigated patients preferences for surgical management of esophageal cancer. Methods We conducted a discrete choice experiment among adult patients who had undergone esophagectomy for adenocarcinoma or squamous cell cancer of the esophagus. Patients preferences were quantified with regression analysis using scenarios based on five aspects: risk of in-hospital mortality, risk of persistent symptoms, chance of 5-year survival, risk of surgical and non-surgical complications, and hospital volume of esophageal cancer surgery. Results The response rate was 68 % (104/142). All aspects proved to influence patients preferences (p \ 0.05). Persisting gastrointestinal symptoms and 5-year survival were the most important attributes, but preferences varied between patients. On average, patients were willing to trade-off 9.5 % (CI %) 5-year survival chance to obtain a surgical treatment with 30 % lower risk of gastrointestinal symptoms, or 8.1 % (CI %) 5-year survival chance for being treated in a high instead of a low-volume hospital. Conclusions Patients are willing to trade-off some 5-year survival chance to achieve an improvement in early outcomes. Given the preference heterogeneity among participants, the present study underlines the importance of a patient-tailored approach when discussing prognosis and treatment. Introduction & Esther W. de Bekker-Grob e.debekker@erasmusmc.nl 1 2 Department of Public Health, Erasmus MC - University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands Department of Surgery, Erasmus MC - University Medical Centre Rotterdam, Rotterdam, The Netherlands Esophageal cancer is an aggressive disease, with a 15 % overall 5-year survival rate [1]. Surgery (i.e., esophagectomy) combined with neoadjuvant therapy offers the best chances for cure but is associated with significant mortality and morbidity rates [2]. Esophagectomy can cause troublesome and persistent gastrointestinal problems and is associated with diminished health-related quality of life [3, 4]. From the patients perspective, optimal surgical management of esophageal cancer weights aspects such as survival chance and (non-)surgical complications, and the experience of the hospital to conduct esophagectomies. To optimize cancer care, it is important for health care providers and policy makers to obtain insight into patients preferences towards surgical management for esophageal cancer, and to elicit the trade-offs that patients make. This insight is not only relevant to meet patients expectations, but also to provide high quality and responsive care [5]. However, quantitative studies investigating patients preferences for surgical management of esophageal cancer are lacking.

2 World J Surg (2015) 39: Table 1 Attributes and attribute levels for surgical management of esophageal cancer Attributes This study investigated patients preferences for surgical management of esophageal cancer and elicited the tradeoffs that patients make. We hereto performed a discrete choice experiment (DCE), a quantitative approach that is increasingly used in healthcare [6]. Materials and methods Levels In-hospital mortality 2 % 5% 10 % Persistent gastrointestinal 10 % symptoms 40 % 80 % 5-year survival after 20 % esophagectomy 35 % 50 % Risk for postoperative 20 % complications (morbidity) 40 % 60 % Hospital volume Low (\10 esophagectomies per year) Medium (10 40 esophagectomies per year) High ([40 esophagectomies per year) Study sample and elicitation mode We identified patients who had undergone an esophagectomy for adenocarcinoma or squamous cell cancer of the esophagus at the Erasmus MC, University Medical Centre Rotterdam, The Netherlands. Patients who were alive and did not have difficulties in understanding the Dutch language were invited to participate in the study. The questionnaire and a prepaid return envelope were mailed to the patients. After 3 weeks, non-responders were sent a reminder. Written informed consent was obtained from all patients. The study was approved by the Medical Ethical Committee of the Erasmus MC University Medical Centre Rotterdam (MEC ). Discrete choice experiment (DCE) In DCEs, it is assumed that a medical intervention, such as a surgical treatment, can be described by its characteristics (attributes; e.g., risk of in-hospital mortality), and that patient s preferences for an intervention are determined by the levels of the attributes (e.g., for risk of in-hospital mortality: 2, 5, and 10 %) [7]. The relative importance of attributes and the trade-offs that patients make between them can be assessed when patients are offered a series of choices between treatment alternatives that have different combinations of attribute levels (see Appendix for an example of a choice set) [8]. Attributes and attribute levels The choice of the most relevant attributes of surgical management of esophageal cancer and their attribute levels was based on literature [9 12], interviews with experienced upper gastrointestinal surgeons (n = 3), and patients who had undergone esophagectomy for esophageal cancer (n = 6; i.e., the target group). These were in-hospital mortality (chance of dying in the hospital after esophagectomy), persistent gastrointestinal (GI) symptoms (development of symptoms postoperatively including dysphagia, feeling of early fullness, nausea, regurgitation, and diarrhea), 5-year survival (chance to be alive without recurrence 5 years after esophagectomy), morbidity (surgical and non-surgical complications during hospital stay requiring medical or surgical treatment), and hospital volume (annual number of esophagectomies per hospital) (Table 1). Study design and questionnaire The combination of five attributes with three levels each resulted in 243 (3 5 ) possible alternatives for surgical management of esophageal cancer. It is not feasible to present a single individual with all these alternatives. We therefore reduced the design in such a way that at least all main effects could be estimated. NGene software ( was used, which is capable of generating designs that are highly efficient (i.e., maximizing D-efficiency or minimizing D-error). As a result, 24 choice sets divided over two versions of the questionnaire were constructed [13]. Each choice set included two surgical alternatives ( Appendix ). Patients were asked to consider the two alternatives in each choice set as realistic alternatives and to choose the alternative that appealed most to them. Each questionnaire started with a detailed description of the attributes and their levels. The main part of each questionnaire comprised 12 choice sets. Furthermore, the following data were collected: age at completing the questionnaire, gender, level of education, and household situation. The questionnaire was pilot tested in an interview-based setting (n = 9) to check for any problems in interpretation and face validity.

3 2494 World J Surg (2015) 39: Table 2 Characteristics of respondents, who completed the discrete choice experiment Characteristics Respondents (n = 97) Statistical analyses Mean Age (years) Characteristics n % Age group (years) \ C Male gender Educational level Lower education Intermediate education Higher education Missing 9 9 Household With partner/family member Single Missing 5 5 The DCE was analyzed by taking each choice among the two surgical alternatives as an observation. The observations were analyzed by a panel mixed logit model to obtain insight into patients preferences and to take preference heterogeneity as well as correlation between the choice tasks completed by each individual into account (since each respondent completed 12 choice tasks) [8]. After testing for linear effects of each continuous attribute, the following utility model was estimated: V ¼ b 0 þ b 1 MORTALITY þ b 2 LONGTERM COMPLICATIONS þ b 3 FIVE YEAR SURVIVAL þ b 4 MORBIDITY þ b 5 HOSPITAL VOLUME MEDIUM þ b 6 HOSPITAL VOLUME HIGH ð1þ in which the coefficients for all attributes were treated as normally distributed random parameters. V represents the utility (preference score) derived for an esophageal surgical alternative. b 0 is a constant and b 1 b 6 are coefficients that indicate the relative weight individuals place on a certain attribute (level). The sign of a coefficient reflects whether the attribute has a positive or negative effect on the utility. The value of each coefficient represents the importance respondents assign to an attribute or attribute level. A statistically significant coefficient (p B 0.05) indicates that individuals differentiated between SD one attribute (or attribute level) and another in making their choices in the DCE. A priori, we expected all attributes to be important. We expected that only the attribute 5-year survival after esophagectomy and the attribute levels of hospital volume would have a positive effect (i.e., a positive sign). We generated relative utility (preference) scores of esophagectomy scenarios based on the estimated coefficients. The higher a relative utility score, the stronger the preference for that particular scenario. Absolute values of V, however, have no direct interpretation [14]. We calculated the preference score (i.e., the mean utility) for a base case scenario, representing esophagectomy in a medium volume hospital with a 5 % risk of in-hospital mortality, 40 % risk of persistent GI symptoms, 35 % chance of 5-years survival, and 40 % risk of complications (morbidity). By changing one or more attribute levels, we obtain insight how each attribute systematically affects the utility score (and rank) relative to the base case. We took all preference heterogeneity into account in calculating the mean utility [15]. Finally, to investigate the willingness to trade-off 5-year survival to achieve an improvement in one of the other attributes, we calculated the ratios between the coefficients of the attributes with the attribute 5 year survival as the denominator. Results Respondents The response rate to the questionnaire was 104/142 (68 %) and 97/104 (93 %) completed the DCE task. These respondents had a mean age of 64 years (SD = 8.8), 70 % were men, 28 % had a higher educational level, and 81 % lived together with a partner or family member (Table 2). DCE results All five attributes proved to influence patients preferences for surgical management of esophageal cancer (p \ 0.05; Table 3). The positive or negative directions of the coefficients were consistent with our a priori hypotheses. The positive sign given to the coefficient 5-year survival indicated that patients preferred a surgical management of esophageal cancer generating an increase of 5-year survival after esophagectomy over surgical management that generates a lower chance of 5-year survival. The negative signs for in-hospital mortality, persistent GI symptoms, and morbidity indicated that patients preferred a surgical management of esophageal cancer with a low risk of negative side effects. Patients significantly preferred a high-volume hospital over a low-volume hospital, even

4 World J Surg (2015) 39: Table 3 Patients preferences for surgical management of esophageal cancer based on a panel mixed logit model Attributes Coefficient Mixed logit value 95 % CI Constant Mean 0.10 (-0.20 to 0.40) SD 0.74* (0.29 to 1.20) In-hospital mortality (per 10 %) Mean -3.67* (-5.03 to -2.30) SD 1.46* (0.57 to 2.35) Persistent GI symptoms (per 10 %) Mean -0.74* (-0.95 to -0.53) SD 0.38* (0.24 to 0.51) 5-year survival (per 10 %) Mean 2.33* (1.12 to 3.55) SD 2.14* (1.36 to 2.92) Morbidity (per 10 %) Mean -0.67* (-0.90 to -0.45) SD 0.38* (0.21 to 0.54) Hospital volume Low (omitted) Mean -1.00* (-1.40 to -0.59) SD Medium Mean 0.11 (-0.16 to 0.38) SD 0.67* (0.38 to 0.96) High Mean 0.89* (0.55 to 1.22) SD 0.92* (0.52 to 1.31) Effects coded variable used for hospital volume. Normal distribution for random coefficients used on all attributes. The value of the omitted term equals the negative sum of the coefficients of the included attribute levels GI gastrointestinal * p \ 0.05 for statistical significance after statistically adjusting for the other attributes related to medical care (in-hospital mortality, persistent GI symptoms and morbidity). All estimated standard deviations were significant, which indicated preference heterogeneity among patients for several attributes of surgical management of esophageal cancer. Utility scores and patients ranks for various surgical management scenarios The preference score (i.e., the mean utility) for the base case scenario (esophagectomy in a medium volume hospital with 5 % in-hospital mortality, 40 % persistent GI symptoms, 35 % 5-year survival, and 40 % morbidity) was 0.67 (Table 4). In other words, the base case scenario was ranked 13 on a list of 21 (hypothetical) surgical treatments for esophageal cancer (Table 4). Especially an increased chance of 5-year survival from 35 to 50 %, or a decrease in risk of long-term GI symptoms from 40 to 10 % had a relatively large positive impact on the utility score and thus on the ranking score (rank 3 and 5, respectively, compared to rank 13 for the base case, all else being equal) (Table 4, scenarios 3 and 2, respectively). A high hospital volume instead of a medium volume hospital had a relatively small positive impact on the ranking (rank 12 compared to rank 13 for the base case, all else being equal) (Table 4, scenario 5). However, surgical managements that patients preferred were not automatically associated with optimal levels for chance of 5-year survival and (absence of) persistent GI symptoms. Holding the chance of 5-year survival constant, patients ranked a surgical management with a higher risk of long-term GI symptoms higher than a surgical management with a lower risk of long-term GI symptoms as long as the levels for risk of in-hospital mortality, risk of surgical complications as well as hospital volume were more optimal (Table 4; scenario 15 compared with scenarios 3 or 14). Similarly, holding the risk of persistent GI symptoms constant, patients ranked a surgical management with a lower chance of 5-year survival higher than a surgical management with a higher chance of 5-year survival as long as the levels for risk of in-hospital mortality, risk of surgical complications as well as hospital volume were more optimal (Table 4; scenario 15 compared with scenarios 2 or 13). This means that patients accepted a less effective surgical treatment or a higher risk of persistent GI symptoms, if esophagectomy took place in a higher volume hospital with a lower risk of in-hospital mortality and morbidity.

5 2496 World J Surg (2015) 39: Table 4 Patients ranks and utility scores of hypothetical surgical treatments for esophageal cancer scenarios In-hospital mortality (%) Persistent GI symptoms (%) 5-year survival (%) Morbidity (%) Hospital volume Utility score Difference in utility score compared to base case Rank Base case Medium One level improvement Scenario Medium Scenario Medium Scenario Medium Scenario Medium Scenario High One level worsening Scenario Medium Scenario Medium Scenario Medium Scenario Medium Scenario Low Mixed level change Scenario High Scenario High Scenario Medium Scenario Medium Scenario Low Scenario Low Scenario High Scenario High Scenario Medium Scenario Low Bold values highlight the change in attribute levels compared to the base case scenario Table 5 Willingness to trade-off 5-year survival chance to achieve an improvement in one of the surgical management of esophageal cancer attributes based on panel mixed logit model Average (n = 97) Willingness to trade 5-year survival (%; CI) Interpretation note To receive a surgical treatment for esophageal cancer In-hospital mortality 3.9 ( ).with 2.5 % less risk of in-hospital mortality Persistent GI symptoms 9.5 ( ).with 30 % less risk of persistent GI symptoms Morbidity 5.8 ( ).with 20 % less risk of morbidity Hospital volume 8.1 ( ).in a high-volume hospital instead of a low-volume hospital The confidence intervals were determined using the Delta Method GI gastrointestinal, CI 95 % confidence interval Willingness to trade-off 5-year survival Based on the expressed preferences, patients showed their willingness to trade-off their chance of 5-year survival to achieve an improvement in one level of the other attributes of surgical management of esophageal cancer (Table 5). On average, patients were willing to trade-off 3.9 % (CI %) 5-year survival chance to obtain a surgical treatment with a 2.5 % lower absolute risk of in-hospital mortality. Patients were willing to trade-off 9.5 % (CI %) or 5.8 % (CI %) 5-year survival to obtain a surgical treatment with 30 % lower absolute risk of GI symptoms or 20 % lower absolute risk of morbidity, respectively. For receiving a surgical treatment in a high-volume hospital instead of a low-volume hospital, patients were willing to trade-off 8.1 % (CI %) 5-year chance, keeping other attributes constant.

6 World J Surg (2015) 39: Discussion Risk of in-hospital mortality, risk of persistent GI symptoms, chance of 5-year survival, risk of surgical and nonsurgical complications, and hospital volume of esophageal cancer surgery all influenced patients preferences for surgical management of esophageal cancer. Patients accepted a less effective surgical treatment or a higher risk of persistent GI symptoms, if esophagectomy took place in a higher volume hospital with a lower risk of in-hospital mortality and morbidity. Patients were willing to trade-off 9.5 % (CI %) 5-year survival chance to obtain a surgical treatment with 30 % lower long-term absolute risk of GI symptoms. Another DCE investigated preferences of patients towards surgery for esophagogastric cancer in the UK and found that long-term treatment outcomes (i.e., quality of life and cure rate) outweighed attributes such as hospital type and a surgeon s reputation [16]. These results are in line with our findings, which showed that especially persistent GI symptoms and 5-year survival had a relatively large impact on patients preferences for surgical management of esophageal cancer. Our finding that patients were prepared to give up life expectancy to avoid side effects of medical intervention was also found by a DCE which focused on patients preferences for the management of non-metastatic prostate cancer [17]. Patients included in our study showed preference heterogeneity for several aspects of surgical management of esophageal cancer. Awareness of differences in personal values regarding surgical management is hence important. This study underlines the importance of a patient-tailored approach for discussing prognosis and treatment, which may have a positive effect on the decision process and outcomes in individual patients. The present study had several limitations. First, although the response rate of 68 % is similar to other DCEs performed [18, 19], this response rate is still not optimal. We cannot exclude selection bias, although the respondents did not differ from the non-respondents in age and sex (data not shown) and matched with the demographics of esophageal cancer patients in the Netherlands [1]. Second, all patients included in our study had experienced surgery for esophageal cancer and therefore knew what they were choosing for in the DCE. This strength is, however, also a limitation. This group of patients may be biased based on their personal experience. Therefore, a prospective study including a pre-operative patient population is recommendable to negate the effect of previous experience on patients choices. Third, it is not fully clear whether patients associate better outcome with higher volume hospitals, and that other aspects of higher volume hospitals are appreciated by patients. It is also possible that patients more easily understood the concept of a high-volume hospital than better outcomes as expressed numerically (in %) for in-hospital mortality and morbidity. Fourth, our study is to some extent specific to the Dutch context, that is, a large number of people living in a small country. This means people do not need to travel far to find a highvolume center, and this might have impacted the volume outcome trade-off reported. Finally, the external validity could have been improved if patients were included who were treated in different hospitals with different volumes. This should be kept in mind for future research. In conclusion, this study showed that patients are willing to trade-off some 5-year survival chance to achieve an improvement in early outcomes. Given the preference heterogeneity among participants, the present study underlines the importance of a patient-tailored approach when discussing prognosis and treatment. Compliance with Ethical Standards Conflict of interest None of the authors have competing interests. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( tivecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

7 2498 World J Surg (2015) 39: Appendix: Example of a choice set Opera on A Opera on B Chance of dying in the hospital after the operation 10% (10 out of 100 patients) 2% (2 out of 100 patients) Persistent symptoms of the GI tract 40% (40 out of 100 patients) 40% (40 out of 100 patients) Chance of being alive 5 years after the operation 50% (50 out of 100 patients) 35% (35 out of 100 patients) Chance of complications after the operation Number of operations for esophageal cancer performed in the hospital Which alternative would you choose? 60% (60 out of 100 patients) Low (less than 10 operations per year) 20% (20 out of 100 patients) High (more than 40 operations per year) References 1. Dikken JL, Lemmens VE, Wouters MW et al (2012) Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer 48: Sjoquist KM, Burmeister BH, Smithers BM et al (2011) Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 12: Poghosyan T, Gaujoux S, Chirica M et al (2011) Functional disorders and quality of life after esophagectomy and gastric tube reconstruction for cancer. J Visc Surg 148:e327 e Lerut TE, van Lanschot JJ (2004) Chronic symptoms after subtotal or partial oesophagectomy: diagnosis and treatment. Best Pract Res Clin Gastroenterol 18: Innes S, Payne S (2009) Advanced cancer patients prognostic information preferences: a review. Palliat Med 23: de Bekker-Grob EW, Ryan M, Gerard K (2012) Discrete choice experiments in health economics: a review of the literature. Health Econ 21: Ryan M (2004) Discrete choice experiments in health care. Br Med J 328: Hensher DA, Rose JM, Greene WH (2005) Applied choice analysis: a primer. Cambridge University Press, Cambridge

8 World J Surg (2015) 39: Wouters MW, Krijnen P, Le Cessie S et al (2009) Volume- or outcome-based referral to improve quality of care for esophageal cancer surgery in The Netherlands. J Surg Oncol 99: Wouters MW, Karim-Kos HE, le Cessie S et al (2009) Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol 16: Courrech Staal EF, Aleman BM, Boot H et al (2010) Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer. Br J Surg 97: Cijs TM, Verhoef C, Steyerberg EW et al (2010) Outcome of esophagectomy for cancer in elderly patients. Ann Thorac Surg 90: Bech M, Kjaer T, Lauridsen J (2011) Does the number of choice sets matter? Results from a web survey applying a discrete choice experiment. Health Econ 20: Louviere J, Hensher DA, Swait JD (2000) Stated choice methods: analysis and application. Cambridge University Press, Cambridge 15. de Bekker-Grob EW, Hofman R, Donkers B et al (2010) Girls preferences for HPV vaccination: a discrete choice experiment. Vaccine 28: Thrumurthy SG, Morris JJ, Mughal MM et al (2011) Discretechoice preference comparison between patients and doctors for the surgical management of oesophagogastric cancer. Br J Surg 98: ; discussion Sculpher M, Bryan S, Fry P et al (2004) Patients preferences for the management of non-metastatic prostate cancer: discrete choice experiment. Br Med J 328: Hol L, de Bekker-Grob EW, van Dam L et al (2010) Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer 102: Damen TH, de Bekker-Grob EW, Mureau MA et al (2011) Patients preferences for breast reconstruction: a discrete choice experiment. J Plast Reconstr Aesthet Surg 64:75 83